Filed: 8/13/2026ACC: 0002102314-26-000005
📋 What this filing means
JONES HILL CAPITAL LP filed this quarterly 13F‑HR report disclosing 29 equity positions with a total reported market value of $470.36M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
29
Positions
$470.36M
Total AUM (reported)
18.38M
Total Shares
Allocation by class
COM$406.31M86.4%
COM NEW$32.54M6.9%
ADS$16.28M3.5%
COM PAR $.01$13.05M2.8%
SPONSORED ADS$2.18M0.5%
Portfolio Concentration
Top 3$153.83M32.7%
4–10$169.99M36.1%
11–25$139.91M29.7%
Rest$6.63M1.4%
Top 3 weight
32.7%
Top 10 weight
68.8%
Voting Authority Distribution
Total shares with voting rights: 18.38M
Sole
Full voting authority
18.38M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole29
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings29
Rows:
BIOMARIN PHARMACEUTICAL INC
SOLEShares1.43M
TypeSH
Market value$81.92M
17.42%
Sole
1.43M
Shared
0.00
None
0.00
GILEAD SCIENCES INC
SOLEShares343.04K
TypeSH
Market value$43.34M
9.21%
Sole
343.04K
Shared
0.00
None
0.00
ARCUTIS BIOTHERAPEUTICS INC
SOLEShares1.09M
TypeSH
Market value$28.57M
6.07%
Sole
1.09M
Shared
0.00
None
0.00
MADRIGAL PHARMACEUTICALS INC
SOLEShares52.55K
TypeSH
Market value$28.21M
6.00%
Sole
52.55K
Shared
0.00
None
0.00
BICARA THERAPEUTICS INC
SOLEShares892.62K
TypeSH
Market value$26.50M
5.63%
Sole
892.62K
Shared
0.00
None
0.00
RELMADA THERAPEUTICS INC
SOLEShares3.66M
TypeSH
Market value$25.29M
5.38%
Sole
3.66M
Shared
0.00
None
0.00
TREVI THERAPEUTICS INC
SOLEShares1.34M
TypeSH
Market value$24.98M
5.31%
Sole
1.34M
Shared
0.00
None
0.00
PHARVARIS N V
SOLEShares677.88K
TypeSH
Market value$23.44M
4.98%
Sole
677.88K
Shared
0.00
None
0.00
XENON PHARMACEUTICALS INC
SOLEShares367.90K
TypeSH
Market value$22.21M
4.72%
Sole
367.90K
Shared
0.00
None
0.00
ANI PHARMACEUTICALS INC
SOLEShares233.81K
TypeSH
Market value$19.35M
4.11%
Sole
233.81K
Shared
0.00
None
0.00
IMMUNOCORE HLDGS PLC
SOLEShares512.86K
TypeSH
Market value$16.28M
3.46%
Sole
512.86K
Shared
0.00
None
0.00
AMYLYX PHARMACEUTICALS INC
SOLEShares894.06K
TypeSH
Market value$16.06M
3.41%
Sole
894.06K
Shared
0.00
None
0.00
INSMED INC
SOLEShares122.38K
TypeSH
Market value$13.05M
2.77%
Sole
122.38K
Shared
0.00
None
0.00
NUVALENT INC
SOLEShares98.44K
TypeSH
Market value$12.16M
2.58%
Sole
98.44K
Shared
0.00
None
0.00
CAPRICOR THERAPEUTICS INC
SOLEShares420.75K
TypeSH
Market value$10.13M
2.15%
Sole
420.75K
Shared
0.00
None
0.00
ACLARIS THERAPEUTICS INC
SOLEShares1.76M
TypeSH
Market value$9.31M
1.98%
Sole
1.76M
Shared
0.00
None
0.00
IMMUNIC INC
SOLEShares539.81K
TypeSH
Market value$8.30M
1.76%
Sole
539.81K
Shared
0.00
None
0.00
ORIC PHARMACEUTICALS INC
SOLEShares747.31K
TypeSH
Market value$8.09M
1.72%
Sole
747.31K
Shared
0.00
None
0.00
TONIX PHARMACEUTICALS HLDG C
SOLEShares625.43K
TypeSH
Market value$7.98M
1.70%
Sole
625.43K
Shared
0.00
None
0.00
SYNDAX PHARMACEUTICALS INC
SOLEShares340K
TypeSH
Market value$7.43M
1.58%
Sole
340K
Shared
0.00
None
0.00
OLEMA PHARMACEUTICALS INC
SOLEShares574.17K
TypeSH
Market value$7.18M
1.53%
Sole
574.17K
Shared
0.00
None
0.00
VIR BIOTECHNOLOGY INC
SOLEShares659.21K
TypeSH
Market value$6.72M
1.43%
Sole
659.21K
Shared
0.00
None
0.00
CORBUS PHARMACEUTICALS HLDGS
SOLEShares653.57K
TypeSH
Market value$6.13M
1.30%
Sole
653.57K
Shared
0.00
None
0.00
DIANTHUS THERAPEUTICS INC
SOLEShares57.10K
TypeSH
Market value$5.57M
1.18%
Sole
57.10K
Shared
0.00
None
0.00
VERTEX PHARMACEUTICALS INC
SOLEShares11.12K
TypeSH
Market value$5.53M
1.17%
Sole
11.12K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
BIOMARIN PHARMACEUTICAL INCSOLE | COM | 1.43M | SH | $81.92M 17.42% | 1.43M | 0.00 | 0.00 |
GILEAD SCIENCES INCSOLE | COM | 343.04K | SH | $43.34M 9.21% | 343.04K | 0.00 | 0.00 |
ARCUTIS BIOTHERAPEUTICS INCSOLE | COM | 1.09M | SH | $28.57M 6.07% | 1.09M | 0.00 | 0.00 |
MADRIGAL PHARMACEUTICALS INCSOLE | COM | 52.55K | SH | $28.21M 6.00% | 52.55K | 0.00 | 0.00 |
BICARA THERAPEUTICS INCSOLE | COM | 892.62K | SH | $26.50M 5.63% | 892.62K | 0.00 | 0.00 |
RELMADA THERAPEUTICS INCSOLE | COM | 3.66M | SH | $25.29M 5.38% | 3.66M | 0.00 | 0.00 |
TREVI THERAPEUTICS INCSOLE | COM | 1.34M | SH | $24.98M 5.31% | 1.34M | 0.00 | 0.00 |
PHARVARIS N VSOLE | COM | 677.88K | SH | $23.44M 4.98% | 677.88K | 0.00 | 0.00 |
XENON PHARMACEUTICALS INCSOLE | COM | 367.90K | SH | $22.21M 4.72% | 367.90K | 0.00 | 0.00 |
ANI PHARMACEUTICALS INCSOLE | COM | 233.81K | SH | $19.35M 4.11% | 233.81K | 0.00 | 0.00 |
IMMUNOCORE HLDGS PLCSOLE | ADS | 512.86K | SH | $16.28M 3.46% | 512.86K | 0.00 | 0.00 |
AMYLYX PHARMACEUTICALS INCSOLE | COM | 894.06K | SH | $16.06M 3.41% | 894.06K | 0.00 | 0.00 |
INSMED INCSOLE | COM PAR $.01 | 122.38K | SH | $13.05M 2.77% | 122.38K | 0.00 | 0.00 |
NUVALENT INCSOLE | COM | 98.44K | SH | $12.16M 2.58% | 98.44K | 0.00 | 0.00 |
CAPRICOR THERAPEUTICS INCSOLE | COM NEW | 420.75K | SH | $10.13M 2.15% | 420.75K | 0.00 | 0.00 |
ACLARIS THERAPEUTICS INCSOLE | COM | 1.76M | SH | $9.31M 1.98% | 1.76M | 0.00 | 0.00 |
IMMUNIC INCSOLE | COM NEW | 539.81K | SH | $8.30M 1.76% | 539.81K | 0.00 | 0.00 |
ORIC PHARMACEUTICALS INCSOLE | COM | 747.31K | SH | $8.09M 1.72% | 747.31K | 0.00 | 0.00 |
TONIX PHARMACEUTICALS HLDG CSOLE | COM NEW | 625.43K | SH | $7.98M 1.70% | 625.43K | 0.00 | 0.00 |
SYNDAX PHARMACEUTICALS INCSOLE | COM | 340K | SH | $7.43M 1.58% | 340K | 0.00 | 0.00 |
OLEMA PHARMACEUTICALS INCSOLE | COM | 574.17K | SH | $7.18M 1.53% | 574.17K | 0.00 | 0.00 |
VIR BIOTECHNOLOGY INCSOLE | COM | 659.21K | SH | $6.72M 1.43% | 659.21K | 0.00 | 0.00 |
CORBUS PHARMACEUTICALS HLDGSSOLE | COM NEW | 653.57K | SH | $6.13M 1.30% | 653.57K | 0.00 | 0.00 |
DIANTHUS THERAPEUTICS INCSOLE | COM | 57.10K | SH | $5.57M 1.18% | 57.10K | 0.00 | 0.00 |
VERTEX PHARMACEUTICALS INCSOLE | COM | 11.12K | SH | $5.53M 1.17% | 11.12K | 0.00 | 0.00 |
Page 1 of 2